HHS has just released the "COVID Community Profile Report," a daily updated snapshot of how COVID-19 is affecting our states and communities

Three studies report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and cancers.

Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level.

A true glimpse into the process of transitioning a practice and how it can be a great solution to the issues facing private practices. Many are struggling,